I think about this as a version of Home Run Derby.

I think about this as a version of Home Run Derby. You have a pitcher, a hitter and the fence. Singles, doubles and triples don’t count. (Although we might be an exception). For the most part, in this contest, it’s just home runs, over the fence. Not many players are invited. Inthis Derby, I think it’s around 100 world-wide. Each entrant gets one chance at the plate.to hit as many over the fence as they can. This isn’t like the Bronx Bombers in 1961 with multiple home run hitters in the Derby. Most of the teams have one hitter in the vaccine derby. I don’t see any of these hitters having a home run record to date, eg how many have successfully developed a SARS vaccine in the past?...which would be evidence of hitting prowess. So let’s just say that on average they start out with an equal chance of winning. Numbers of home runs roughly corresponds to the vaccine development cycle...from ‘doesn’t harm you’ to ‘can manufacture 500 million doses in a short period of time (the winner!) Generex is just another entrant. They are, as of today...sending 33 untested but still participating hitters up to the plate to take swings. In three weeks their peptide evaluation might reduce the number of Generex hitters still participating to 5 (if we’re really lucky) or perhaps just one like most of the other teams represented...but still in the contest. [Although Generex is slightly different because it might turn out that a Generex vaccine is composed of multiple peptides. In that case you might get ‘an exception’..and get to add the home runs of multiple Generex hitters]. But I’m not kidding myself. The odds of winning are very long against each and every entrant. Remember, winning is defined as ‘an effective vaccine maker that can quickly manufacture 500 million doses’. Effective. Quickly. 500 million. Quite a tall order. Just for today I’m comfortable with our odds. In another month we might be back on the bench. But today we’re still in the game. Go Generex!